Weight loss can reverse the cardiovascular changes that take place in the heart, but will a new diet and exercise work, or is ...

Despite competitive pressures in the obesity market, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 drugs.

Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...

Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...

Trials have confirmed the efficacy of GLP-1 RAs in achieving clinically sustained weight loss in people with obesity without diabetes.

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past ...

Could the same medication that causes people to lose weight hold the key to reducing drinking? In a new paper at the European ...

A North Texas woman with a cautionary tale warns others to do their research before starting popular weight loss drugs.

Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was ...

Turns out you can actually die from a broken heart.